The first cardiac transplant experience in a patient with mucopolysaccharidosis

Cardiovasc Pathol. 2012 Jul-Aug;21(4):358-60. doi: 10.1016/j.carpath.2011.10.004. Epub 2011 Dec 6.

Abstract

Hunter syndrome (MPSII) is a rare X-linked lysosomal storage disorder that can affect multiple systems but primarily affects the heart. We report the case of a previously asymptomatic 23-year-old patient who had an attenuated form of MPSII and presented with refractory heart failure that required a heart transplant. The diagnosis was confirmed by detection of an increase in urinary excretion of glycosaminoglycans, a deficiency in enzymatic activity, and molecular analysis. A myocardial biopsy revealed hypertrophic cardiomyocytes, mild fibrosis, and lysosomal storage in interstitial cells. Molecular analysis identified a novel mutation in the iduronate-2-sulfatase gene. Although the clinical outcome was not favorable, we believe that this approach may be valid in end-stage heart failure.

Publication types

  • Case Reports

MeSH terms

  • Echocardiography, Doppler
  • Family Health
  • Fatal Outcome
  • Female
  • Fibrosis / complications
  • Fibrosis / pathology
  • Heart Failure / etiology
  • Heart Failure / surgery*
  • Heart Transplantation
  • Humans
  • Hypertrophy
  • Lysosomes / pathology
  • Male
  • Mucopolysaccharidosis II / complications
  • Mucopolysaccharidosis II / diagnosis
  • Mucopolysaccharidosis II / surgery*
  • Mutation
  • Myocytes, Cardiac / pathology
  • Sulfatases
  • Sulfotransferases / genetics
  • Young Adult

Substances

  • Sulfotransferases
  • SULF2 protein, human
  • Sulfatases